Maria Amaya MD PhD
@mariaamaya27.bsky.social
Physician Scientist, University of Colorado | MDS, AML |
Full article is finally out! Venetoclax and oral azacitidine is safe and showed excellent responses in newly diagnosed AML patients.
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
October 4, 2026 at 12:53 AM
Full article is finally out! Venetoclax and oral azacitidine is safe and showed excellent responses in newly diagnosed AML patients.
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Reposted by Maria Amaya MD PhD
Join us in congratulating Wells Messersmith, MD, who has been named director of the University of Colorado Anschutz Cancer Center (@cucancercenter.bsky.social), effective October 1. Read the full announcement here: https://news.cuanschutz.edu/medicine/messersmith-director-cancer-center
September 21, 2026 at 4:10 PM
Join us in congratulating Wells Messersmith, MD, who has been named director of the University of Colorado Anschutz Cancer Center (@cucancercenter.bsky.social), effective October 1. Read the full announcement here: https://news.cuanschutz.edu/medicine/messersmith-director-cancer-center
Reposted by Maria Amaya MD PhD
CU Anschutz Cancer Center's Maria Amaya (@mariaamaya27.bsky.social), MD, PhD, shares why last Friday's Mentored Member Collaborative Forum is important for mentored members like herself.
September 14, 2026 at 10:19 PM
CU Anschutz Cancer Center's Maria Amaya (@mariaamaya27.bsky.social), MD, PhD, shares why last Friday's Mentored Member Collaborative Forum is important for mentored members like herself.
We had so much fun at the myeloid meeting and congrats to Keishla on her poster! Until next time!
May 22, 2026 at 12:03 AM
We had so much fun at the myeloid meeting and congrats to Keishla on her poster! Until next time!
Our lab, the Lego version!
April 27, 2026 at 2:44 PM
Our lab, the Lego version!
Reposted by Maria Amaya MD PhD
The ASCEND program aims to coordinate and accelerate cell and gene therapy clinical trials—an area rich with promise, but complex in execution. Learn more about this new chapter in the CU Anschutz’s commitment to patients with serious and rare diseases: https://bit.ly/4cr0jPT
Powering ASCEND: Translational Strength and Campuswide Collaboration
The Accelerating Solutions for Cell and Gene Therapy Evaluation and Novel Delivery (ASCEND) was created to coordinate and accelerate cell and gene therapy clinical trials at CU Anschutz. Gates Institu...
bit.ly
April 22, 2026 at 6:44 PM
The ASCEND program aims to coordinate and accelerate cell and gene therapy clinical trials—an area rich with promise, but complex in execution. Learn more about this new chapter in the CU Anschutz’s commitment to patients with serious and rare diseases: https://bit.ly/4cr0jPT
Had an amazing time at ALF 2026, many great and inspirational talks!
April 17, 2026 at 8:25 PM
Had an amazing time at ALF 2026, many great and inspirational talks!
Great day at the department of medicine research day! So proud of the team and especially proud Keishla for winning an abstract award! @cudeptofmedicine.bsky.social
April 14, 2026 at 11:15 PM
Great day at the department of medicine research day! So proud of the team and especially proud Keishla for winning an abstract award! @cudeptofmedicine.bsky.social
Coming up later this month is AML World Awareness Day! So tomorrow morning at 8:30am, we will be talking about AML in the radio show “Hablemos Hoy” (Emisora La Buena Honda 1150AM) in Spanish!
April 13, 2026 at 8:46 PM
Coming up later this month is AML World Awareness Day! So tomorrow morning at 8:30am, we will be talking about AML in the radio show “Hablemos Hoy” (Emisora La Buena Honda 1150AM) in Spanish!
Reposted by Maria Amaya MD PhD
For our local Colorado cancer researchers @cucancercenter.bsky.social @nucleosomepolice.bsky.social @cucancerbio.bsky.social
January 16, 2026 at 1:30 PM
For our local Colorado cancer researchers @cucancercenter.bsky.social @nucleosomepolice.bsky.social @cucancerbio.bsky.social
It’s been a tough year so sun, palm trees is what we needed to end the year! 🌴🌴🌴🌴☀️☀️🕶️
December 29, 2025 at 7:02 PM
It’s been a tough year so sun, palm trees is what we needed to end the year! 🌴🌴🌴🌴☀️☀️🕶️
The work of a talented trainee with biorender! Happy holidays from the Amaya and Marchetti’s labs! Couldn’t ask for a more amazing group of people to work with 💕
December 16, 2025 at 10:48 PM
The work of a talented trainee with biorender! Happy holidays from the Amaya and Marchetti’s labs! Couldn’t ask for a more amazing group of people to work with 💕
That’s a wrap for me for #ASH25! So many great things! Oral therapies for myeloid malignancies, aza/ven for the win for AML, CDK inhibitors to avoid t-MN? And can we finally give IV iron to pts with infections? Also, ASH daycare always saves the day!
December 8, 2025 at 11:47 PM
That’s a wrap for me for #ASH25! So many great things! Oral therapies for myeloid malignancies, aza/ven for the win for AML, CDK inhibitors to avoid t-MN? And can we finally give IV iron to pts with infections? Also, ASH daycare always saves the day!
Reposted by Maria Amaya MD PhD
A huge thanks to Dr Manali Kamdar, of @cuanschutz.bsky.social, for stopping by during #ASH25 to discuss long-term follow-up data from the TRANSFORM study of liso-cel in R/R LBCL! See our site for more #lymsm insights from the meeting! @ash.hematology.org #hematology
www.onclive.com/conference/ash
www.onclive.com/conference/ash
December 6, 2025 at 7:34 PM
A huge thanks to Dr Manali Kamdar, of @cuanschutz.bsky.social, for stopping by during #ASH25 to discuss long-term follow-up data from the TRANSFORM study of liso-cel in R/R LBCL! See our site for more #lymsm insights from the meeting! @ash.hematology.org #hematology
www.onclive.com/conference/ash
www.onclive.com/conference/ash
Day 1 of ASH ✅
Excited to see more friends over the weekend!
Excited to see more friends over the weekend!
December 6, 2025 at 12:02 AM
Day 1 of ASH ✅
Excited to see more friends over the weekend!
Excited to see more friends over the weekend!
So proud of Dr. Cassandra Duarte for publishing this important study with the help of the Flatiron database!
“Impact of demographic factors on clinical outcomes of patients with acute myeloid leukemia”
haematologica.org/newsletter/v...
“Impact of demographic factors on clinical outcomes of patients with acute myeloid leukemia”
haematologica.org/newsletter/v...
Early View
| Haematologica
haematologica.org
September 20, 2025 at 3:42 AM
So proud of Dr. Cassandra Duarte for publishing this important study with the help of the Flatiron database!
“Impact of demographic factors on clinical outcomes of patients with acute myeloid leukemia”
haematologica.org/newsletter/v...
“Impact of demographic factors on clinical outcomes of patients with acute myeloid leukemia”
haematologica.org/newsletter/v...
Reposted by Maria Amaya MD PhD
A US Senate committee endorsed maintaining the NIH's structure and increasing its funding by US$400 million, or about 1%
go.nature.com/4mg193S
go.nature.com/4mg193S
‘Congress has your back’: US senators tell scientists they want to protect NIH budget
Senate budget bill includes small increase for the health-research agency — but faces a long road before being signed into law.
go.nature.com
August 1, 2025 at 1:14 PM
A US Senate committee endorsed maintaining the NIH's structure and increasing its funding by US$400 million, or about 1%
go.nature.com/4mg193S
go.nature.com/4mg193S
Reposted by Maria Amaya MD PhD
Congrats to my friend James DeGregori and his partner Mercedes Rincon and everyone involved on this beautiful study!
Hidden in the lungs of some breast cancer survivors are tumour cells that can remain dormant for decades — until they one day trigger a relapse
go.nature.com/41iIdJR
go.nature.com/41iIdJR
‘Sleeping’ cancer cells in the lungs can be roused by COVID and flu
Inflammation from the respiratory infections seems to be the culprit, study in mice finds.
go.nature.com
July 31, 2025 at 6:23 AM
Congrats to my friend James DeGregori and his partner Mercedes Rincon and everyone involved on this beautiful study!
Reposted by Maria Amaya MD PhD
Reposted by Maria Amaya MD PhD
Orientation week is over and we are excited to have the new first years on rotation with us!
July 9, 2025 at 3:26 PM
Orientation week is over and we are excited to have the new first years on rotation with us!
Outcomes of oral azacitidine and venetoclax in newly diagnosed AML. High responses in TP53 mut patients. www.vjhemonc.com/video/wmkfly...
Outcomes with an all-oral regimen of CC-486 and venetoclax in patients with newly diagnosed AML
Maria Amaya, MD, PhD, University of Colorado Anschutz Medical Campus, Aurora, CO, presents the results from a clinical study (NCT05287568)...
www.vjhemonc.com
June 18, 2025 at 3:59 PM
Outcomes of oral azacitidine and venetoclax in newly diagnosed AML. High responses in TP53 mut patients. www.vjhemonc.com/video/wmkfly...
Come check out our poster tonight! EHA2025
June 14, 2025 at 8:50 AM
Come check out our poster tonight! EHA2025
Reposted by Maria Amaya MD PhD
Congratulations to Maria Amaya, MD, PhD, Assistant Professor of Medicine-Hematology (and CU HemeOnc Fellowship alumni) on being selected as one of the 2025 Translational Research Scholars. Each scholar receives research support over four years. #CUAnschutz #CUCancer
June 10, 2025 at 5:43 PM
Congratulations to Maria Amaya, MD, PhD, Assistant Professor of Medicine-Hematology (and CU HemeOnc Fellowship alumni) on being selected as one of the 2025 Translational Research Scholars. Each scholar receives research support over four years. #CUAnschutz #CUCancer